ReviewRheumatology international2021

Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review.

Avgoustina Kyriakou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.